Led by Caroline Huber, Associate Director of Policy and Economics, a surprising new study was recently published in The Journal of Infectious Diseases, estimating the overlooked social, economic and health impacts of the 2013-2016 West Africa Ebola crisis.
Lessons Learned from the Oncology Care Model Implementation: Maximizing the Value of Health Economics Evidence—presented by PHE Senior Economist and former Congressional Budget Office Deputy Assistant Director, Dr. James Baumgardner, and PHE Scientific Advisor, Dr. Wade Aubry, former Chief Medical Officer of Blue Shield of California. […]
This unique webinar addresses current standards of cost-effectiveness analysis- including limitations and challenges- and reviews often overlooked sources of value and the importance of these alternative value assessments in discussions with payers, policymakers, and other stakeholders (w/Q&A session following webinar presentation). […]
PHE Chief Scientific Officer Darius Lakdawalla delivered the keynote presentation at the AJMC’s ACO & Emerging Healthcare Delivery Coalition, held May 4th-5th in Scottsdale, Arizona. Dr. Lakdawalla’s keynote focused on value frameworks, and provided an economic perspective on value frameworks, the various frameworks out there and what they measure, and what elements are missing from current frameworks.
For more information, or to learn how to change your cookies preferences, please click here.